Which has the lower trailing P/E, BSX or HUM?

BSX has the lower trailing P/E: BSX trades at 18.31 and HUM at 38.58. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BSX or HUM?

Over the past five years, BSX grew revenue faster — BSX at a 13.40% CAGR versus HUM at 12.61%.

Does BSX or HUM pay a bigger dividend?

HUM pays a dividend (0.86% yield), while BSX has no payments in the available dividend history.

Is BSX or HUM more profitable?

BSX runs the higher net margin — BSX at 17.47% versus HUM at 0.88%.

How have BSX and HUM total returns compared?

Over the past 10 years, BSX delivered 6.22% and HUM delivered 9.71% annualized total return. Past performance doesn't predict future results.

Boston Scientific Corporation (BSX) vs Humana Inc. (HUM)

A side-by-side comparison of Boston Scientific Corporation and Humana Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

BSX

Boston Scientific Corporation

$66.96B

$45.05HealthcareDelayed quote: Sep 14, 2026, 4:00 PM EDT

HUM

Humana Inc.

$48.93B

$407.45HealthcareDelayed quote: Sep 14, 2026, 4:00 PM EDT

Total return — BSX vs HUM

growth of $100 · dividends reinvested · last 10y

BSX +82.8% (+6.2%/yr)HUM +152.8% (+9.7%/yr)HUM compounded faster over this window

BSX HUM

BSX vs HUM: by the numbers

•BSX is the larger company ($66.96B vs $48.93B market cap).
•BSX trades at the lower trailing earnings multiple (18.31 vs 38.58 P/E), one valuation lens rather than an overall verdict.
•BSX converts more revenue to profit (17.47% vs 0.88% net margin).
•BSX grew revenue faster over the past five years (13.40% vs 12.61% CAGR).
•HUM pays a dividend (0.86% yield), while BSX has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	BSX	HUM
P/E ratio	18.31	38.58
Forward P/E	13.70	44.51
P/S ratio	3.19	0.34
P/B ratio	2.69	2.55
EV / EBITDA	13.64	20.30
FCF yield	5.41%	N/A

Profitability

Metric	BSX	HUM
Gross margin	71.16%	13.65%
Operating margin	21.46%	1.39%
Net margin	17.47%	0.88%
ROE	14.71%	6.65%
ROIC	10.57%	4.52%

Dividends

Metric	BSX	HUM
Dividend yield	N/A	0.86%
Payout ratio	N/A	33.52%

Growth (annualized)

Metric	BSX	HUM
Revenue CAGR (5Y)	13.40%	12.61%
EPS CAGR (5Y)	N/A	-17.27%
FCF CAGR (5Y)	15.64%	-17.19%
Total return CAGR (5Y)	-0.67%	1.39%

Frequently asked

Which has the lower trailing P/E, BSX or HUM?: BSX has the lower trailing P/E: BSX trades at 18.31 and HUM at 38.58. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BSX or HUM?: Over the past five years, BSX grew revenue faster — BSX at a 13.40% CAGR versus HUM at 12.61%.
Does BSX or HUM pay a bigger dividend?: HUM pays a dividend (0.86% yield), while BSX has no payments in the available dividend history.
Is BSX or HUM more profitable?: BSX runs the higher net margin — BSX at 17.47% versus HUM at 0.88%.
How have BSX and HUM total returns compared?: Over the past 10 years, BSX delivered 6.22% and HUM delivered 9.71% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BSX analysis Full HUM analysis Interactive comparison tool

Dig into the metrics

Boston Scientific P/E ratio Humana P/E ratio Humana dividend yield Boston Scientific ROE Humana ROE Boston Scientific operating margin Humana operating margin Boston Scientific revenue growth Humana revenue growth Boston Scientific free cash flow Humana free cash flow

Boston Scientific & Humana appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.